Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Frontiers in Oncology|July 12, 2017
Enhancing the Oncolytic Activity of CD133-Targeted Measles Virus: Receptor Extension or Chimerism with Vesicular Stomatitis Virus Are Most EffectiveDina Kleinlützum, Julia D S Hanauer, Alexander Muik, et al.
Plos One|June 2, 2016
APOBEC4 Enhances the Replication of HIV-1Daniela Marino, Mario Perković, Anika Hain, et al.
Scientific Reports|December 6, 2017
Antigen-specific oncolytic MV-based tumor vaccines through presentation of selected tumor-associated antigens on infected cells or virus-like particlesStefan Hutzler, Stephanie Erbar, Robert A Jabulowsky, et al.
Molecular Therapy. Oncology|February 3, 2026
A measles virus encoding a CD19/CD3 bispecific T cell engager shows enhanced preclinical anti-BCP-ALL efficacy without significant toxicitySabine Heinze, Giovanna L Stadler, Yonghui Zhang, et al.
Molecular Therapy Oncolytics|February 19, 2019
Measles Virus-Based Treatments Trigger a Pro-inflammatory Cascade and a Distinctive Immunopeptidome in GlioblastomaSrinath Rajaraman, Denis Canjuga, Michael Ghosh, et al.
Journal of Virology|January 23, 2015
High secretion of interferons by human plasmacytoid dendritic cells upon recognition of Middle East respiratory syndrome coronavirusVivian A Scheuplein, Janna Seifried, Anna H Malczyk, et al.
Retrovirology|March 4, 2011
Mutation of a diacidic motif in SIV-PBj Nef impairs T-cell activation and enteropathic diseaseUlrich Tschulena, Ralf Sanzenbacher, Michael D Mühlebach, et al.
Cancer Research|January 8, 2013
Specific elimination of CD133+ tumor cells with targeted oncolytic measles virusPatricia Bach, Tobias Abel, Christopher Hoffmann, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 6, 2013
DARPin-targeting of measles virus: unique bispecificity, effective oncolysis, and enhanced safetyKatrin Friedrich, Jan Rh Hanauer, Steffen Prüfer, et al.
Journal of Virology|June 19, 2015
Lentiviral Protein Transfer Vectors Are an Efficient Vaccine Platform and Induce a Strong Antigen-Specific Cytotoxic T Cell ResponseKatharina M Uhlig, Stefan Schülke, Vivian A M Scheuplein, et al.
Pageof 5